Sectors Covered   Completed Transactions   Testimonials   Principals   M&A Report 
 and Publications 
 Contact Us 












Dynamic Healthcare M&A Database - 2Q07



Return to the Summary Page (2Q07)



Acquiring Party    Integra LifeSciences Holdings Corporation (NASDAQ:IART), a manufacturer of regenerative medical devices focused on neurosurgery, extremity reconstruction, orthopedics and general surgery.
Transferring Party    LXU Healthcare Inc., a leading manufacturer of fiber optic headlight systems for the medical industry through its Luxtec brand.
Sector    Medical Devices
Date    May 8, 2007
Analysis
Luxtec's headlight systems are used by over 50,000 surgeons worldwide and provides the Jarit sales organization (part of Integra) with increased exposure and growth opportunities in the hospital and ambulatory surgery center market, including various key surgical specialties. Approximately 40% of Luxtec products are used by cardiovascular surgeons, 20% by general surgeons, 10% by neurosurgeons and 7% each by ENT and orthopedic surgeons. Deal Value -- $30m, on LXU revenue of $49.4m(0.6x) and EBITDA of $2.6m (11.6x).




The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones.

This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc.


The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.